Cellares, Inc.

Cellares, Inc. is a privately-held life sciences technology company that automates cell therapy manufacturing. Cellares is advancing the Cell Shuttle, which enables end-to-end automation of the process of creating highly-individualized cell therapies, including CAR-T therapies currently used to treat blood cancers by modifying and growing cells from the patient's own immune system to attack cancer cells. Cellares, Inc. was founded in 2019 by Alex Pesch, Fabian Gerlinghaus, and Omar Kurdi. Cellares, Inc. headquarters are located in South San Francisco, California.

a life sciences technology company that automates cell therapy manufacturing, raises $50MM Series D from Prime Radiant Partners.


a sciences technology company that automates cell therapy manufacturing, raises $257MM Series D from BlackRock Private Equity Partners.